Funding issues key to early medicines access scheme in UK
This article was originally published in SRA
Work on a UK scheme that could allow patients to have earlier access to certain innovative medicines will be completed in the coming year despite problems over how it might be funded, the Medicines and healthcare Products Regulatory Agency has said in its annual business plan for 2013-20141,2.
You may also be interested in...
A draft EU guideline explains how disease registries can be used to supplement evidence in the pre-authorization phase and provide infrastructure for post-authorization evidence generation.
Companies are being encouraged to become “early adopters” of the EU Clinical Trials Information System when it goes live in December 2021.
Drug companies will be able to “play around” with the new EU Clinical Trials Information System in a secure testing environment before it goes live in approximately 15 months.